A detailed history of Russell Investments Group, Ltd. transactions in Haemonetics Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 36,600 shares of HAE stock, worth $3.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,600
Previous 35,605 2.79%
Holding current value
$3.32 Million
Previous $2.95 Million 0.14%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$72.45 - $91.58 $72,087 - $91,122
995 Added 2.79%
36,600 $2.94 Million
Q2 2024

Aug 08, 2024

SELL
$81.24 - $97.37 $10,398 - $12,463
-128 Reduced 0.36%
35,605 $2.95 Million
Q1 2024

May 08, 2024

BUY
$71.24 - $85.35 $58,986 - $70,669
828 Added 2.37%
35,733 $3.05 Million
Q4 2023

Feb 05, 2024

BUY
$80.59 - $92.61 $161,663 - $185,775
2,006 Added 6.1%
34,905 $2.98 Million
Q3 2023

Nov 13, 2023

SELL
$82.56 - $93.49 $536,227 - $607,217
-6,495 Reduced 16.49%
32,899 $2.95 Million
Q2 2023

Aug 10, 2023

SELL
$80.84 - $89.45 $143,410 - $158,684
-1,774 Reduced 4.31%
39,394 $3.35 Million
Q1 2023

May 09, 2023

BUY
$72.75 - $90.6 $660,788 - $822,919
9,083 Added 28.31%
41,168 $3.41 Million
Q4 2022

Feb 08, 2023

BUY
$73.85 - $86.14 $111,218 - $129,726
1,506 Added 4.92%
32,085 $2.52 Million
Q3 2022

Nov 04, 2022

SELL
$63.3 - $78.66 $3.52 Million - $4.37 Million
-55,586 Reduced 64.51%
30,579 $2.26 Million
Q2 2022

Jul 29, 2022

BUY
$49.27 - $66.08 $385,242 - $516,679
7,819 Added 9.98%
86,165 $5.61 Million
Q1 2022

May 05, 2022

SELL
$43.77 - $63.22 $137,700 - $198,890
-3,146 Reduced 3.86%
78,346 $4.95 Million
Q4 2021

Jan 21, 2022

SELL
$49.55 - $74.59 $11.6 Million - $17.4 Million
-233,234 Reduced 74.11%
81,492 $4.32 Million
Q3 2021

Nov 08, 2021

BUY
$57.6 - $70.59 $3.84 Million - $4.71 Million
66,684 Added 26.88%
314,726 $22.2 Million
Q2 2021

Aug 04, 2021

BUY
$51.81 - $118.56 $11.1 Million - $25.3 Million
213,440 Added 616.84%
248,042 $16.5 Million
Q1 2021

May 10, 2021

BUY
$111.01 - $139.48 $310,494 - $390,125
2,797 Added 8.79%
34,602 $3.84 Million
Q4 2020

Feb 08, 2021

SELL
$88.75 - $119.95 $232,880 - $314,748
-2,624 Reduced 7.62%
31,805 $3.78 Million
Q3 2020

Nov 09, 2020

SELL
$75.65 - $93.58 $1.66 Million - $2.05 Million
-21,929 Reduced 38.91%
34,429 $3 Million
Q2 2020

Aug 05, 2020

SELL
$84.96 - $118.91 $3.48 Million - $4.87 Million
-40,929 Reduced 42.07%
56,358 $5.04 Million
Q1 2020

May 06, 2020

SELL
$74.34 - $121.82 $7.18 Million - $11.8 Million
-96,588 Reduced 49.82%
97,287 $9.78 Million
Q4 2019

Jan 29, 2020

SELL
$114.37 - $129.46 $3.83 Million - $4.33 Million
-33,457 Reduced 14.72%
193,875 $22.2 Million
Q3 2019

Nov 01, 2019

SELL
$117.16 - $138.52 $181,363 - $214,428
-1,548 Reduced 0.68%
227,332 $28.4 Million
Q2 2019

Aug 09, 2019

SELL
$81.74 - $120.34 $3.49 Million - $5.14 Million
-42,726 Reduced 15.73%
228,880 $27.4 Million
Q1 2019

May 13, 2019

BUY
$83.25 - $102.12 $1.31 Million - $1.61 Million
15,741 Added 6.15%
271,606 $23.5 Million
Q4 2018

Feb 11, 2019

SELL
$90.66 - $116.63 $7.69 Million - $9.9 Million
-84,875 Reduced 24.91%
255,865 $25 Million
Q3 2018

Oct 26, 2018

BUY
$89.96 - $114.58 $12.6 Million - $16.1 Million
140,505 Added 70.17%
340,740 $38.8 Million
Q2 2018

Aug 08, 2018

BUY
$71.53 - $95.75 $4.77 Million - $6.39 Million
66,748 Added 50.0%
200,235 $17.9 Million
Q1 2018

May 11, 2018

BUY
$60.72 - $74.41 $3.63 Million - $4.45 Million
59,769 Added 81.08%
133,487 $9.77 Million
Q4 2017

Feb 06, 2018

BUY
$44.96 - $58.99 $1.43 Million - $1.87 Million
31,737 Added 75.6%
73,718 $4.3 Million
Q3 2017

Nov 07, 2017

BUY
$40.38 - $44.87 $1.7 Million - $1.88 Million
41,981
41,981 $1.88 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.66B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.